Most Popular Documents

See which documents other people are reading and reviewing most often. The list is updated on a regular basis to give you the most current information.

Displaying Most Popular Documents

23 articles

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Document Status: Current
ID: GL-C50-27

Nov 2021

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer

Document Status: Current
ID: GL 27-2
Version: 2

Feb 2021

Follow-up Care, Surveillance Protocols and Secondary Prevention Measures for Survivors of Colorectal Cancer

Document Status: Current
ID: GL 26-2
Version: 3

Mar 2021

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current
ID: GL 4-1
Version: 2

Jan 2021

Overarching Policy for the Screening of Trans People in the Ontario Breast Screening Program and the Ontario Cervical Screening Program

Document Status: Current
ID: N/A
Version: 2.1

Sep 2021

Position Statements for Nursing Practice in Cancer Care

Document Status: Current
Version: 2

May 2021

Provincial Plan for Focal Tumour Ablation Services

Document Status: Current
ID: GL-C50-32

Jan 2021

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current
Version: 2

Dec 2021

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Document Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Radiation Oncology Peer Review Guidance Document

Document Status: Current
ID: GL-C50-10
Version: 1

May 2021

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Document Status: Current

Apr 2021

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Document Status: Current
ID: GL 1-23-A

Jul 2021